Literature DB >> 3668518

Effects of oral aspartame on plasma phenylalanine in humans and experimental rodents. Short note.

R J Wurtman1, T J Maher.   

Abstract

All aspartame does given to humans cause greater elevations in plasma (and, presumably, brain) phenylalanine than in plasma tyrosine. In contrast, doses of aspartame usually used in experiments on rodents preferentially elevate tyrosine. Since phenylalanine can inhibit brain catecholamine synthesis while tyrosine is the antidote for this effect, we determined the aspartame dose that would be needed to elevate phenylalanine more than tyrosine in rodents, using published data. In general rodents need 60 times as much aspartame, on a mg/kg basis, as humans to obtain comparable elevations in phenylalanine with respect to tyrosine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3668518     DOI: 10.1007/bf01252517

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  15 in total

1.  Migraine provoked by aspartame.

Authors:  D R Johns
Journal:  N Engl J Med       Date:  1986-08-14       Impact factor: 91.245

2.  Effect of aspartame loading upon plasma and erythrocyte amino acid levels in phenylketonuric heterozygotes and normal adult subjects.

Authors:  L D Stegink; L J Filer; G L Baker; J E McDonnell
Journal:  J Nutr       Date:  1979-04       Impact factor: 4.798

3.  The effect of phenylalanine and its metabolites on glucose utilization in developing brain.

Authors:  K F Swaiman; B Lemieux
Journal:  J Neurochem       Date:  1969-03       Impact factor: 5.372

4.  Aspartame: possible effect on seizure susceptibility.

Authors:  R J Wurtman
Journal:  Lancet       Date:  1985-11-09       Impact factor: 79.321

5.  Neurochemical changes following high-dose aspartame with dietary carbohydrates.

Authors:  R J Wurtman
Journal:  N Engl J Med       Date:  1983-08-18       Impact factor: 91.245

6.  Tyrosine availability determines stimulus-evoked dopamine release from rat striatal slices.

Authors:  J D Milner; R J Wurtman
Journal:  Neurosci Lett       Date:  1985-08-30       Impact factor: 3.046

7.  Effects of phenylalanine on the release of endogenous dopamine from rat striatal slices.

Authors:  J D Milner; K Irie; R J Wurtman
Journal:  J Neurochem       Date:  1986-11       Impact factor: 5.372

8.  Acute effects of aspartame on systolic blood pressure in spontaneously hypertensive rats.

Authors:  P J Kiritsy; T J Maher
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

9.  Acute effects of oral or parenteral aspartame on catecholamine metabolism in various regions of rat brain.

Authors:  H Yokogoshi; R J Wurtman
Journal:  J Nutr       Date:  1986-03       Impact factor: 4.798

10.  Plasma, erythrocyte and human milk levels of free amino acids in lactating women administered aspartame or lactose.

Authors:  L D Stegink; L J Filer; G L Baker
Journal:  J Nutr       Date:  1979-12       Impact factor: 4.798

View more
  4 in total

1.  The effect of phenylalanine on DOPA synthesis in PC12 cells.

Authors:  F R DePietro; J D Fernstrom
Journal:  Neurochem Res       Date:  1998-07       Impact factor: 3.996

2.  Oral aspartame and plasma phenylalanine: pharmacokinetic difference between rodents and man, and relevance to CNS effects of phenylalanine. Short note.

Authors:  J D Fernstrom
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

3.  Aspartame and seizures.

Authors:  P C Jobe; J W Dailey
Journal:  Amino Acids       Date:  1993-10       Impact factor: 3.520

Review 4.  Pharmacological effects of phenylalanine on seizure susceptibility: an overview.

Authors:  P Y Sze
Journal:  Neurochem Res       Date:  1989-02       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.